These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 6134240)

  • 41. [Secondary prevention of myocardial infarct].
    Kotsev G
    Vutr Boles; 1984; 23(2):55-9. PubMed ID: 6146228
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 43. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 44. Platelets and prostaglandins in sudden death: therapeutic implications.
    Gelman JS; Mehta J
    Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
    [No Abstract]   [Full Text] [Related]  

  • 45. [Prevention of recurrent myocardial infarct].
    Kallio V
    Duodecim; 1981; 97(5):227-30. PubMed ID: 6113128
    [No Abstract]   [Full Text] [Related]  

  • 46. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 48. Secondary prevention after myocardial infarction: a review of long-term trials.
    May GS; Eberlein KA; Furberg CD; Passamani ER; DeMets DL
    Prog Cardiovasc Dis; 1982; 24(4):331-52. PubMed ID: 6119737
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
    Bousser MG
    Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464
    [No Abstract]   [Full Text] [Related]  

  • 51. Initiative raises use of interventions that prevent second heart attacks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2000 Jul; 11(14):8-10. PubMed ID: 11771563
    [No Abstract]   [Full Text] [Related]  

  • 52. [Basic program of myocardial infarct after-care].
    Holtz H
    Z Gesamte Inn Med; 1990 Sep; 45(18):547-9. PubMed ID: 1981291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
    Mannucci PM
    G Ital Cardiol; 1983 Nov; 13(11):335-9. PubMed ID: 6667821
    [No Abstract]   [Full Text] [Related]  

  • 55. [Secondary prevention of myocardial infarct. Drug therapy].
    Widimský J
    Vnitr Lek; 1982 Mar; 28(3):248-56. PubMed ID: 6126041
    [No Abstract]   [Full Text] [Related]  

  • 56. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 57. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
    Ostendorf P
    Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265
    [No Abstract]   [Full Text] [Related]  

  • 59. Myocardial infarction.
    Prentice CR
    Clin Haematol; 1981 Jun; 10(2):521-41. PubMed ID: 7032787
    [No Abstract]   [Full Text] [Related]  

  • 60. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.